SCHEMBL4314577

SCHEMBL4314577

Cc1ccc(S(=O)(=O)O)c([C@@H]2CCOC2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.37
EPHX2 P34913 9/20 0.35
PRKAB2 O43741 1/20 0.34
PRKAG1 P54619 1/20 0.34
PRKAA2 P54646 1/20 0.34
PRKAA1 Q13131 1/20 0.34
PRKAG3 Q9UGI9 1/20 0.34
PRKAG2 Q9UGJ0 1/20 0.34
PRKAB1 Q9Y478 1/20 0.34
CNR2 P34972 2/20 0.33
LMNA P02545 1/20 0.33
MCOLN3 Q8TDD5 1/20 0.33
F2 P00734 1/20 0.32
PLG P00747 1/20 0.32
PLAU P00749 1/20 0.32
PLAT P00750 1/20 0.32
KLK1 P06870 1/20 0.32
PRSS1 P07477 1/20 0.32
CFTR P13569 1/20 0.32
HCRTR1 O43613 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1613058 1.00 ALDH1A1 (0.37) ALDH1A1EPHX2PRKAB2PRKAG1PRKAA2
SCHEMBL4321244 1.00 ALDH1A1 (0.37) ALDH1A1EPHX2PRKAB2PRKAG1PRKAA2
SCHEMBL28509421 0.92 PTGDR2 (0.35) ALDH1A1EPHX2LMNAHCRTR1HCRTR2
SCHEMBL1121066 0.91 ALDH1A1 (0.42) ALDH1A1EPHX2PRKAB2PRKAG1PRKAA2
SCHEMBL5792421 0.88 ALDH1A1 (0.35) ALDH1A1EPHX2LMNAMCOLN3
SCHEMBL17476551 0.83 ALDH1A1 (0.36) ALDH1A1EPHX2CNR2LMNAMCOLN3
SCHEMBL9101971 0.83 PTGDR2 (0.39) ALDH1A1EPHX2MCOLN3HCRTR1HCRTR2
SCHEMBL30764027 0.80 PTGDR2 (0.43) EPHX2MCOLN3HCRTR1HCRTR2
SCHEMBL5278348 0.80 PTGDR2 (0.47) ALDH1A1EPHX2LMNA
SCHEMBL16712212 0.80 CHRNB2 (0.43) ALDH1A1EPHX2LMNAMCOLN3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114907284-A Compound with anti-tumor activity and application thereof 石药集团中奇制药技术(石家庄)有限公司 2022-08-16 CN disclosed
WO-2020125779-A1 8-SUBSTITUTED STYRYL XANTHINE DERIVATIVES AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2020-06-25 WO disclosed
EP-2894151-A1 IMIDAZOLINE DERIVATIVES, PREPARATION METHODS THEREOF, AND THEIR APPLICATIONS IN MEDICINE Shanghai Hengrui Pharmaceutical Co. Ltd. (CN) 2015-07-15 EP disclosed
US-7615648-B2 Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake ELI LILLY AND COMPANY (US) 2009-11-10 US disclosed
US-20080004330-A1 Aminomethyl-Azacycle Derivatives as Inhibitors of Monoamine Uptake ELI LILLY AND COMPANY 2008-01-03 US disclosed
EP-1756050-A1 AMINOMETHYL-AZACYCLE DERIVATIVES AS INHIBITORS OF MONOAMINE UPTAKE ELI LILLY AND COMPANY (US) 2007-02-28 EP disclosed
WO-2005118531-A1 AMINOMETHYL-AZACYCLE DERIVATIVES AS INHIBITORS OF MONOAMINE UPTAKE ELI LILLY AND COMPANY (US) 2005-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004330-A1 Aminomethyl-Azacycle Derivatives as Inhibitors of Monoamine Uptake SLC6A2, TPH1, SLC6A3 ALDH1A1 279/4885EPHX2 3261/4885PRKAB2 3590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.